TOPIC CENTER
818 Articles
Updated Oct 7, 2026
Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
Regulatory & ComplianceBIOSECURE Act Excluded from U.S. Defense Bill, Boosting Chinese Biotech Firms
4 min read • 2 years ago -
Funding & InvestmentsSK pharmteco Unifies Global CDMO Brands to Streamline Drug Development Services
4 min read • 2 years ago -
-
-
Funding & InvestmentsOutsource or Die? How CDMOs Will Shape Pharma in 2025 and Beyond
4 min read • 2 years ago -
Funding & Investments
BioDuro Appoints Alan Findlater as New Chief Commercial Officer
4 min read • 2 years ago -
-
-
NewsDyadic Secures Gates Foundation Grant to Develop Affordable Antibodies for RSV and Malaria
4 min read • 2 years ago -
Funding & Investments
Bristol Myers Squibb Implements Layoffs in New Jersey Amid Cost-Cutting Measures
4 min read • 2 years ago -
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
